BRPI0922303A2 - arilciclo-hexiléteres de di-hidrotetra-azabenzoazulenos para o uso como antagonistas do receptor de vasopressina v1a - Google Patents
arilciclo-hexiléteres de di-hidrotetra-azabenzoazulenos para o uso como antagonistas do receptor de vasopressina v1aInfo
- Publication number
- BRPI0922303A2 BRPI0922303A2 BRPI0922303A BRPI0922303A BRPI0922303A2 BR PI0922303 A2 BRPI0922303 A2 BR PI0922303A2 BR PI0922303 A BRPI0922303 A BR PI0922303A BR PI0922303 A BRPI0922303 A BR PI0922303A BR PI0922303 A2 BRPI0922303 A2 BR PI0922303A2
- Authority
- BR
- Brazil
- Prior art keywords
- dihydrotetraazabenzoazulenes
- arylcyclohexylethers
- receptor antagonists
- vasopressin receptor
- vasopressin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08170188 | 2008-11-28 | ||
PCT/EP2009/065354 WO2010060836A1 (en) | 2008-11-28 | 2009-11-18 | Arylcyclohexylethers of dihydrotetraazabenzoazulenes for use as vasopressin via receptor antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
BRPI0922303A2 true BRPI0922303A2 (pt) | 2016-01-12 |
BRPI0922303B1 BRPI0922303B1 (pt) | 2019-11-12 |
Family
ID=41382009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0922303-7A BRPI0922303B1 (pt) | 2008-11-28 | 2009-11-18 | arilciclo-hexiléteres de di-hidrotetra-azabenzoazulenos, seu processo de preparação, composição farmacêutica que os compreende e uso |
Country Status (32)
Country | Link |
---|---|
US (2) | US8227458B2 (pt) |
EP (1) | EP2370441B1 (pt) |
JP (1) | JP5452608B2 (pt) |
KR (1) | KR101359742B1 (pt) |
CN (1) | CN102227428B (pt) |
AR (2) | AR074409A1 (pt) |
AU (1) | AU2009319123B2 (pt) |
BR (1) | BRPI0922303B1 (pt) |
CA (1) | CA2743976C (pt) |
CO (1) | CO6341478A2 (pt) |
CR (1) | CR20110220A (pt) |
CY (1) | CY1115435T1 (pt) |
DK (1) | DK2370441T3 (pt) |
EC (1) | ECSP11011089A (pt) |
ES (1) | ES2431279T3 (pt) |
HK (1) | HK1160642A1 (pt) |
HR (1) | HRP20131067T1 (pt) |
IL (1) | IL212122A (pt) |
MA (1) | MA32781B1 (pt) |
MX (1) | MX2011005596A (pt) |
MY (1) | MY150837A (pt) |
NZ (1) | NZ592076A (pt) |
PE (1) | PE20110582A1 (pt) |
PL (1) | PL2370441T3 (pt) |
PT (1) | PT2370441E (pt) |
RU (1) | RU2507205C2 (pt) |
SG (1) | SG171846A1 (pt) |
SI (1) | SI2370441T1 (pt) |
TW (1) | TWI379833B (pt) |
UA (1) | UA103504C2 (pt) |
WO (1) | WO2010060836A1 (pt) |
ZA (1) | ZA201103419B (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011143366A1 (en) * | 2010-05-13 | 2011-11-17 | Amgen Inc. | Heteroaryloxycarbocyclyl compounds as pde10 inhibitors |
US8828989B2 (en) * | 2011-09-26 | 2014-09-09 | Hoffmann-La Roche Inc. | Oxy-cyclohexyl-4H,6H-5-oxa-2,3,10b-triaza-benzo[E]azulenes as V1A antagonists |
CA2847095A1 (en) * | 2011-10-05 | 2013-04-11 | F. Hoffmann-La Roche Ag | Cyclohexyl-4h,6h-5-oxa-2,3,10b-triaza-benzo[e]azulenes as v1a antagonists |
PE20160203A1 (es) | 2013-08-19 | 2016-04-20 | Hoffmann La Roche | Antagonistas de via para tratar trastornos del sueno por cambio de fase |
CA2931016C (en) | 2013-12-05 | 2022-11-01 | F. Hoffmann-La Roche Ag | Synthesis of trans-8-chloro-5-methyl-1-[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulene and crystalline forms thereof |
WO2017191117A1 (en) | 2016-05-03 | 2017-11-09 | Bayer Pharma Aktiengesellschaft | V1a receptor antagonists for use in the treatment of renal diseases |
RU2666598C1 (ru) * | 2017-07-14 | 2018-09-11 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" | Средство для коррекции расстройств аутистического спектра |
US11033601B2 (en) | 2017-09-14 | 2021-06-15 | The Regents Of The University Of Colorado, A Body Corporate | Selective inhibition of V1b for treating fatty liver |
KR20200097702A (ko) * | 2017-12-08 | 2020-08-19 | 에프. 호프만-라 로슈 아게 | 약학 제형 |
HU231206B1 (hu) | 2017-12-15 | 2021-10-28 | Richter Gedeon Nyrt. | Triazolobenzazepinek |
TW201938171A (zh) | 2017-12-15 | 2019-10-01 | 匈牙利商羅特格登公司 | 作為血管升壓素V1a受體拮抗劑之三環化合物 |
WO2020139670A1 (en) | 2018-12-27 | 2020-07-02 | Teva Pharmaceuticals International Gmbh | Solid state forms of balovaptan |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5521173A (en) | 1995-01-17 | 1996-05-28 | American Home Products Corporation | Tricyclic benzazepine vasopressin antagonists |
WO2000043398A2 (en) * | 1999-01-19 | 2000-07-27 | Ortho-Mcneil Pharmaceutical, Inc. | Tricyclic benzodiazepines as vasopressin receptor antagonists |
TWI239333B (en) * | 2000-11-16 | 2005-09-11 | Hoffmann La Roche | Benzodiazepine derivatives as GABA A receptor modulators |
US7022699B2 (en) | 2001-04-12 | 2006-04-04 | Wyeth | Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators |
GB0303852D0 (en) | 2003-02-19 | 2003-03-26 | Pfizer Ltd | Triazole compounds useful in therapy |
GB0400700D0 (en) * | 2004-01-13 | 2004-02-18 | Pfizer Ltd | Compounds useful in therapy |
KR100840852B1 (ko) | 2004-05-25 | 2008-06-23 | 화이자 프로덕츠 인크. | 테트라아자벤조[e]아줄렌 유도체 및 이의 유사체 |
BRPI0510273A (pt) * | 2004-05-25 | 2007-10-30 | Pfizer Prod Inc | derivados de tetraazabenzo[e]azuleno e análogos destes |
EP1632494A1 (en) | 2004-08-24 | 2006-03-08 | Ferring B.V. | Vasopressin v1a antagonists |
WO2006021882A1 (en) * | 2004-08-25 | 2006-03-02 | Pfizer Limited | Triazolobenzodiazepines and their use as vasopressin antagonists |
EP1877399A1 (en) | 2005-04-26 | 2008-01-16 | Pfizer Limited | Triazole derivatives as vasopressin antagonists |
US20080234252A1 (en) | 2005-05-18 | 2008-09-25 | Pfizer Inc | Compounds Useful in Therapy |
EP2104677B1 (en) | 2007-01-12 | 2011-12-07 | F. Hoffmann-La Roche AG | Spiropiperidine glycinamide derivatives |
KR101159060B1 (ko) * | 2008-04-09 | 2012-07-03 | 가부시키가이샤 구라레 | 가스 배리어성 적층체 및 이의 제조방법 |
CA2741018A1 (en) | 2008-11-13 | 2010-05-20 | F. Hoffmann-La Roche Ag | Spiro-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulenes |
MX2011005119A (es) * | 2008-11-18 | 2011-05-30 | Hoffmann La Roche | Alquilciclohexileteres de dihidrotetraazabenzoazulenos. |
US8420633B2 (en) | 2010-03-31 | 2013-04-16 | Hoffmann-La Roche Inc. | Aryl-cyclohexyl-tetraazabenzo[e]azulenes |
US8461151B2 (en) * | 2010-04-13 | 2013-06-11 | Hoffmann-La Roche Inc. | Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes |
US8492376B2 (en) * | 2010-04-21 | 2013-07-23 | Hoffmann-La Roche Inc. | Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes |
US8481528B2 (en) * | 2010-04-26 | 2013-07-09 | Hoffmann-La Roche Inc. | Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes |
US8513238B2 (en) | 2010-05-10 | 2013-08-20 | Hoffmann-La Roche Inc. | Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenes |
-
2009
- 2009-11-18 NZ NZ592076A patent/NZ592076A/en unknown
- 2009-11-18 SI SI200930769T patent/SI2370441T1/sl unknown
- 2009-11-18 RU RU2011123703/04A patent/RU2507205C2/ru active
- 2009-11-18 EP EP09752380.7A patent/EP2370441B1/en active Active
- 2009-11-18 BR BRPI0922303-7A patent/BRPI0922303B1/pt active IP Right Grant
- 2009-11-18 JP JP2011537933A patent/JP5452608B2/ja active Active
- 2009-11-18 CA CA2743976A patent/CA2743976C/en active Active
- 2009-11-18 PE PE2011001019A patent/PE20110582A1/es active IP Right Grant
- 2009-11-18 MY MYPI20112399 patent/MY150837A/en unknown
- 2009-11-18 KR KR1020117012049A patent/KR101359742B1/ko active IP Right Grant
- 2009-11-18 AU AU2009319123A patent/AU2009319123B2/en active Active
- 2009-11-18 CN CN200980147825.3A patent/CN102227428B/zh active Active
- 2009-11-18 DK DK09752380.7T patent/DK2370441T3/da active
- 2009-11-18 ES ES09752380T patent/ES2431279T3/es active Active
- 2009-11-18 UA UAA201107950A patent/UA103504C2/ru unknown
- 2009-11-18 MX MX2011005596A patent/MX2011005596A/es active IP Right Grant
- 2009-11-18 SG SG2011038692A patent/SG171846A1/en unknown
- 2009-11-18 PT PT97523807T patent/PT2370441E/pt unknown
- 2009-11-18 WO PCT/EP2009/065354 patent/WO2010060836A1/en active Application Filing
- 2009-11-18 PL PL09752380T patent/PL2370441T3/pl unknown
- 2009-11-19 US US12/621,547 patent/US8227458B2/en active Active
- 2009-11-25 TW TW098140192A patent/TWI379833B/zh active
- 2009-11-26 AR ARP090104565A patent/AR074409A1/es active IP Right Grant
-
2011
- 2011-03-31 CO CO11039945A patent/CO6341478A2/es active IP Right Grant
- 2011-04-04 IL IL212122A patent/IL212122A/en active IP Right Grant
- 2011-04-28 CR CR20110220A patent/CR20110220A/es unknown
- 2011-05-10 ZA ZA2011/03419A patent/ZA201103419B/en unknown
- 2011-05-10 MA MA33827A patent/MA32781B1/fr unknown
- 2011-05-26 EC EC2011011089A patent/ECSP11011089A/es unknown
-
2012
- 2012-02-02 HK HK12100967.5A patent/HK1160642A1/xx unknown
- 2012-05-15 US US13/471,491 patent/US8461152B2/en active Active
-
2013
- 2013-10-24 CY CY20131100939T patent/CY1115435T1/el unknown
- 2013-11-08 HR HRP20131067AT patent/HRP20131067T1/hr unknown
-
2018
- 2018-07-16 AR ARP180101972 patent/AR112338A2/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0922303A2 (pt) | arilciclo-hexiléteres de di-hidrotetra-azabenzoazulenos para o uso como antagonistas do receptor de vasopressina v1a | |
BRPI0913930A2 (pt) | antagonistas de receptores de prostaglandinas d2 | |
BRPI0919844A2 (pt) | compostos de azaindazol como antagonistas do receptor ccr1 | |
BRPI0923512A2 (pt) | antagonistas de receptores de ácido lisofosfatídico | |
DK2501703T3 (da) | Spiropiperidinforbindelser som orl-1-receptorantagonister | |
BRPI0821141A2 (pt) | Derivados de heteroarila como antagonistas do receptor de orexina | |
BRPI1014572A2 (pt) | imidazoprazinas para uso como inibidores de cinase | |
BRPI0911563A2 (pt) | uso de antagonista da progesterona | |
BRPI0813768A2 (pt) | Derivados de benzazepina úteis como antagonistas de vasopressina | |
BRPI0909157A2 (pt) | compostos heterocíclicos como antagonistas de receptores de adenosina | |
BRPI0910118A2 (pt) | antagonistas de receptores do glucagon | |
DK2501704T3 (da) | Spiropiperidinforbindelser som oral-1-receptorantagonister | |
BRPI0907364A2 (pt) | Antagonistas aminoalquilbifenil n,n-disubstituídos de receptores d2 de prostaglandina | |
BRPI0717023A2 (pt) | Tiazol pirazolopirimidina como antagonistas do receptor de crf1 | |
DK2821407T3 (da) | Piperidinoncarboxamidazaindan-cgrp receptorantagonister | |
DK2252581T3 (da) | Kappa-selektiv opioidreceptorantagonist | |
BRPI1015367A2 (pt) | imidazotiodiazois para uso como inibidores de cinase | |
ATE517100T1 (de) | Pyrrolidinarylether als nk3-rezeptorantagonisten | |
ATE519738T1 (de) | Pyrrolidinarylether als nk3-rezeptorantagonisten | |
BRPI0817061A2 (pt) | Derivados de pirrolidinilalquilisoquinolinona e -isoindolinona como antagonistas de histamina-3 | |
BRPI0815797A2 (pt) | Compostos 8-azabiciclo[3.2.1]octil-2-hidroxibanzamida como antagonistas de receptor opióide mu | |
EP2254413A4 (en) | IMIDAZOBENZAZEPIN-CGRP receptor antagonists | |
BRPI0814767A2 (pt) | Derivados de monoamida como antagonistas do receptor de orexina | |
BRPI0913267A2 (pt) | uso do ácido succínico | |
BRPI1011036A2 (pt) | uso |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/11/2009, OBSERVADAS AS CONDICOES LEGAIS. (CO) 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/11/2009, OBSERVADAS AS CONDICOES LEGAIS |